Christopher Moore

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA

Matthew A. Coelho, Sophie de Carné Trécesson, Sareena Rana et al. · Immunity · 2017 · 644 citations · Full text

Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer

Míriam Molina‐Arcas, Christopher Moore, Sareena Rana et al. · Science Translational Medicine · 2019 · 219 citations

The CATERPILLER Protein Monarch-1 Is an Antagonist of Toll-like Receptor-, Tumor Necrosis Factor α-, and Mycobacterium tuberculosis-induced Pro-inflammatory Signals

Kristi L. Williams, John D. Lich, Joseph A. Duncan et al. · Journal of Biological Chemistry · 2005 · 213 citations · Full text

Microbial Pathogens, Toll-like Receptor-, Immunology +25

Requirement for Interaction of PI3-Kinase p110α with RAS in Lung Tumor Maintenance

Esther Castellano, Clare Sheridan, May Zaw Thin et al. · Cancer Cell · 2013 · 186 citations · Full text

Enteroviruses Harness the Cellular Endocytic Machinery to Remodel the Host Cell Cholesterol Landscape for Effective Viral Replication

Marianita Santiana, Nai-Yun Hsu, Wenli Du et al. · Cell Host & Microbe · 2013 · 149 citations · Full text

Viral Replication, Molecular Virology, Medicine +8